NDC 0409-3390-11 - Piperacillin and Tazobactam

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0409-3390
Requested NDC: 0409-3390-11
Package NDCs from labels: 0409-3390-11, 0409-3390-04, 0409-3390-10
Manufacturer: Hospira, Inc
Effective date: 2024-10-25
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Piperacillin and Tazobactam - Hospira, Inc	Hospira, Inc	2024-10-25	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0409-3390-04	Piperacillin and Tazobactam	10 in 1 CARTON	INJECTION, POWDER, LYOPHILIZED,	10	28
0409-3390-10	Piperacillin and Tazobactam	10 in 1 CARTON	INJECTION, POWDER, LYOPHILIZED,	10	28
0409-3390-11	Piperacillin and Tazobactam	20 mL in 1 VIAL, SINGLE-USE	INJECTION, POWDER, LYOPHILIZED,	20	28

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-3390	PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC]	25	Current NDC, Legacy NDC, 3 package rows	20241218_4d3f4b69-b0b9-494f-9cda-4537fa420d47.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0409-3390-04	EA - Each	0409-3390	9a15f3a0-6eae-4f60-a143-1b30743ea741	1	2012-07-24
0409-3390-10	EA - Each	0409-3390	e30c043b-652b-4518-95ed-71442a9fb663	1	2025-07-08
0409-3390-11	EA - Each	0409-3390	05aad8c1-3822-4721-8e1c-c2e0a7900e42	1	2019-06-19

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PIPERACILLIN SODIUM	ACTIVE INGREDIENT	M98T69Q7HP	PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC]	13
TAZOBACTAM SODIUM	ACTIVE INGREDIENT	UXA545ABTT	PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC]	13
PIPERACILLIN ANHYDROUS	ACTIVE MOIETY	9I628532GX	PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC]	13
TAZOBACTAM	ACTIVE MOIETY	SE10G96M8W	PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC]	13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 37 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Zosyn	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Baxter Healthcare Corporation	8db6bd91-2106-4bfd-8cc8-38aaf1e18d17	2026-05-15	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
ZERBAXA	CEFTOLOZANE AND TAZOBACTAM	Merck Sharp & Dohme LLC	70ac1d90-eff3-4f0b-9f46-5846c571b32f	2026-05-12	Warnings, Adverse reactions	Exact identifier unii: UXA545ABTT
Piperacillin and Tazobactam and Sodium Chloride	PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE	B. Braun Medical Inc.	a63ca653-27d4-45fe-a744-77e0efe45220	2026-05-08	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Civica, Inc.	19e89f8b-316b-4dd2-9724-bfe0faeba408	2025-12-12	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	WG Critical Care, LLC	2cd82553-79dc-45f0-9755-2c08df524ed5	2025-10-31	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
piperacillin and tazobactam	PIPERACILLIN AND TAZOBACTAM	Civica, Inc.	7aebc0e6-89db-4ef0-b5ab-d6b3199bcfc4	2025-09-08	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Avenacy, LLC	668a2730-e95a-4639-a506-ae95a6502ca1	2025-09-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Eugia US LLC	39e19789-de4b-4fd1-ab1c-92f59496f496	2025-08-19	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Eugia US LLC	a5d8625e-e630-4076-bc55-46ebe861c6a5	2025-08-08	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
piperacillin and tazobactam	PIPERACILLIN AND TAZOBACTAM	ONESOURCE SPECIALTY PHARMA LIMITED	28258745-12e4-4f0f-b318-4a1a1bebc928	2025-07-21	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Avenacy, LLC	9114cea1-3338-487e-87fa-cc3a409d501a	2025-07-07	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	BluePoint Laboratories	1aba753c-d0c2-4b35-917a-9143dd4be468	2025-06-20	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Apotex Corp.	2c8f06a2-49b2-4169-94ef-182d13d248bf	2025-05-21	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Fresenius Kabi USA, LLC	c5cddf50-e486-4ffb-9bc6-ed67ad6bc154	2025-04-14	Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Fresenius Kabi USA, LLC	6a894b94-171f-4217-81a2-0e84796b0b41	2025-04-11	Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Provepharm Inc.	68d5384d-1691-4afc-8a1a-488f8e2ef2c5	2025-02-26	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: M98T69Q7HP unii: UXA545ABTT
PIPERACILLIN AND TAZOBACTAM	PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM	Provepharm Inc.	bc26ffd8-1a6e-4e16-91c1-ec67c928b3bf	2025-02-26	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Sandoz Inc	9b682c66-61c6-4ade-baf4-9d68911a16b8	2024-10-30	Warnings, Adverse reactions	Exact identifier application number: ANDA065362 rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Hospira, Inc	4d3f4b69-b0b9-494f-9cda-4537fa420d47	2024-10-25	Warnings, Adverse reactions	Exact identifier application number: ANDA065362 ndc (package): 0409-3385-15 ndc (package): 0409-3385-13 ndc (package): 0409-3390-10 ndc (package): 0409-3390-11 ndc (package): 0409-3383-10 ndc (package): 0409-3383-02 ndc (package): 0409-3390-04 ndc (package): 0409-3383-11 ndc (package): 0409-3385-11 ndc (product): 0409-3383 ndc (product): 0409-3390 ndc (product): 0409-3385 ndc11 (package): 00409339011 rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 spl id: fd775790-2345-483f-ba4c-4d4898da3450 spl set id: 4d3f4b69-b0b9-494f-9cda-4537fa420d47 unii: M98T69Q7HP unii: UXA545ABTT
Piperacillin and Tazobactam	PIPERACILLIN AND TAZOBACTAM	Shandong Anxin Pharmaceutical Co., Ltd.	420196a5-f62d-473f-84d8-d7fc3f31c3d3	2024-10-17	Warnings, Adverse reactions	Exact identifier rxcui: 1659137 rxcui: 1659131 rxcui: 1659149 unii: M98T69Q7HP unii: UXA545ABTT

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.